Perspective Therapeutics (CATX) Cash from Operations (2010 - 2026)

Perspective Therapeutics (CATX) has 17 years of Cash from Operations data on file, last reported at 31468000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 45.81% year-over-year to 31468000.0; the trailing twelve-month figure through Mar 2026 stood at 92370000.0 (down 71.93% YoY), and the FY2025 full-year result was 82484000.0, down 350.88% from the prior year.
• Cash from Operations eased to 31468000.0 in Q1 2026, from 24657000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 13848000.0 in Q1 2024 to a low of 31468000.0 in Q1 2026.
• A 5-year average of 11003647.06 and a median of 9008000.0 in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations jumped 242.43% in 2024 and sank 584.02% in 2025, its largest moves.
• Tracing CATX's Cash from Operations over 5 years: stood at 6086000.0 in 2022, then plunged by 48.01% to 9008000.0 in 2023, then tumbled by 195.36% to 26606000.0 in 2024, then advanced by 7.33% to 24657000.0 in 2025, then slipped by 27.62% to 31468000.0 in 2026.
• Business Quant data shows CATX's Cash from Operations at 31468000.0 in Q1 2026, 24657000.0 in Q4 2025, and 16292000.0 in Q3 2025.